Randomized, double-blind trial of telbivudine versus lamivudine in adults with decompensated chronic hepatitis B and evidence of cirrhosis.
Phase of Trial: Phase III
Latest Information Update: 11 Dec 2014
At a glance
- Drugs Telbivudine (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 15 Apr 2010 Two-year results were reported in an oral session at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL) held in Vienna, Austria, on 14th-18th Apr 2010.
- 30 Mar 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 30 Mar 2010 Planned number of patients (232) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History